Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.4832
H.R.4832: Prescription Drug Comparative Effectiveness Act of 2002
About This Bill
- This bill was introduced in the 107th Congress
- This bill is primarily about congress
- Introduced May 23, 2002
- Latest Major Action June 3, 2002
Bill Sponsor
Bill Cosponsors
19 (All Democrats)
Bill Summary
Prescription Drug Comparative Effectiveness Act of 2002 - Directs the Director of the Agency for Healthcare Research and Quality to study, analyze, and report to Congress on valid scientific evidence regarding the comparative effectiveness and cost-effectiveness, relative to other drugs and treatments, of prescription drugs that account for high levels of expenditures or use by individuals entitled to benefits under titles XVIII (Medicare) or...
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
Referred to the House Committee on Energy and Commerce.
|
|
Referred to the Subcommittee on Health.
|
|
May 23, 2002 |
Introduced in the House by Thomas H. Allen (D-Maine) |